The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...

In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...

BD, Medtronic and Abbott were among the top 10 medical device manufacturers with the highest number of late reports, the ...

The U.S. FDA and HHS announced on Tuesday a set of actions and initiatives focused on infant formula to ensure the ongoing quality, safety, nutritional adequacy and resilience of the domestic infant ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot.

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust CAGR of 27.5%, reaching US$1967.7 million in 2024 and an impressive US$8438.5 ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

The U.S. government sold $13 billion of 20-year bonds on Tuesday at a lower-than-expected yield, underpinned by strong appetite from international and domestic bidders.

J.P. Morgan resumed coverage of Rio Tinto (NYSE:RIO) with an “Overweight” rating and a price target of £59.20 per share, citing roughly 20% share price upside driven by strong copper growth, ...